Literature DB >> 35154642

Corrigendum: High-dose non-sedating antihistamines are used insufficiently in chronic urticaria patients treated with omalizumab.

.   

Abstract

[This corrects the article DOI: 10.1002/clt2.12085.].
© 2022 The Authors. Clinical and Translational Allergy published by John Wiley and Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.

Entities:  

Year:  2022        PMID： 35154642      PMCID： PMC8825443          DOI： 10.1002/clt2.12120

Source DB:  PubMed          Journal:  Clin Transl Allergy        ISSN： 2045-7022            Impact factor:   5.871


In [1], the Figure 1 was incorrect and should have been corrected. The correct Figure 1 should be:
  1 in total

1.  High-dose non-sedating antihistamines are used insufficiently in chronic urticaria patients treated with omalizumab.

Authors:  Hanne Madsen; Charlotte G Mortz; Carsten Bindslev-Jensen; Mette Reilev; Jesper Hallas; Daniel P Henriksen
Journal:  Clin Transl Allergy       Date:  2021-12-11       Impact factor: 5.871
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.